Monday, August 12, 2019 - Anti-HIV transmission drugs like Truvada and Descovy are being hailed as the tip of the spear in an international effort to wipe out AIDs, once thought of as a death sentence disease. Truvada is a pre-exposure prophylactic (PReP) drug meaning a non-HIV infected person takes the daily medication to prevent transmission from their HIV positive sex partner. The United States has taken the lead from countries like Australia to form an initiative to get Truvada into the hands of as many targeted candidates for the drug as possible. Candidates for the free giveaway include HIV negative gay men engaged in a sexual relationship with an HIV infected partner. The US Center for Disease Control, in coordination with the Trump Administration and Gilead Pharmaceuticals, maker of Truvada, are slated to giveaway 2.1 million bottles of Truvada every year free of charge. According to SeekingAlpha.com, "Gilead Sciences has agreed to provide up to 2.4M bottles of Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) each year to the U.S. Centers for Disease Control and Prevention (CDC) in support of national efforts to help prevent HIV for uninsured Americans at risk of infection." Truvada lawsuit attorneys representing Americans harmed from Truvada broken bones and kidney failure side effects and offer a free consultation.
Truvada has a 99% effective rate when used as directed and in combination with condoms. Truvada is to be used with other safe sex practices such as being in a monogamous relationship, using a condom, and of course abstinence. Other nations such as Australia where medicine is socialized, have been selling Truvada its citizens for only $28 US dollars per month, a fraction of the $1900 monthly charge people pay in the United States leading many to ask the question "What good is medication if people can't afford it?"
Unfortunately, Truvada's effectiveness has had the unwanted effect of acting as licenses for many young adults to stop using condoms and to engage in non-protected sex and as a result, other sexually transmitted diseases have started to skyrocket. The steady decline in HIV infections in major US cities has been more than offset by an explosion in the number of cases of sexually transmitted diseases. According to The Post and Courier.com, "Chlamydia, gonorrhea and syphilis cases hit an all-time high in 2017," Dr. Gail Bolan, director of the division of STD Prevention for Atlanta-based Centers for Disease Control and Prevention, said during a recent STD conference. "CDC is seeing steep and sustained increases in STDs." In addition to encouraging risky sexual practices, Truvada may not be the panacea for health that HIV researchers claim it is. There is ample and growing evidence based on actual FDA-reported cases that Truvada may cause bone density loss leading to leg and hip fractures. While experts are optimistic that bone density decay may be reversed in short-term Truvada users (less than one year), there is no guarantee that permanent bone loss could occur for longer-term users. If this proves to be the case, HIV negative Truvada patients could be swapping a risk of one deadly disease for a likelihood of contracting another.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.